Edward Fishman on Bloomberg: Global Energy Policy
Edward Fishman joins Bloomberg on October 30, 2025. Edward Fishman is one of the world’s foremost experts on economic statecraft, with deep experience shaping U.S.…
Thought Leader: Edward Fishman
FDA Needs To Change How It Regulates Novel Technologies
January 12, 2016
Source: Link
By Scott Gottlieb (original source Forbes)
“I spoke before a meeting of the International Society for Stem Cell Research in Berkeley, Calif., this week, addressing the need for the Food and Drug Administration to adapt how it approaches pre-market regulation in order to properly address very novel areas of technology like gene editing and cell and gene therapy.
The thrust of my message was this: FDA needs to more closely focus is organizational structure and its regulatory programs on measures of risk, and move away from its structural legacy that oriented its review programs mostly around discrete clinical areas of medicine.”
Click here to read more
Relevant and recent posts
4 Strategies Providers Are Using to Strengthen the Healthcare Workforce
During Reuters’ Total Health conference in Chicago, four healthcare leaders shared the strategies they believe will help fortify the workforce for the future. Healthcare’s workforce crisis continues…
Thought Leader: Dave Chokshi
Lisa Bodell: Smart Leaders Sabotage Their Own Strategies
Traditional strategic planning is often more of a ritual than a breakthrough moment. Teams gather, review last year’s metrics, and churn out a cookie-cutter annual…
Thought Leader: Lisa Bodell